The Valley Desk

NCT00655837 · Interventional trial

Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCL

Overall registry status Completed

Phase 1

Conditions Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov